United Therapeutics director exercises 650 RSUs
UNITED THERAPEUTICS Corp director Nilda Mesa reported the vesting and conversion of equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp director Nilda Mesa reported the vesting and conversion of equity awards. On July 9, 2026, 650 restricted stock units vested and were converted on a one-for-one basis into 650 shares of common stock. Following this compensation-related transaction, Mesa directly holds 5,678 shares of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2 | 650 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 650 | $0.00 | $0.00 |
Footnotes (2)
- F1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.
- F2. Not applicable as restricted stock units do not have an expiration date.
Key Figures
Key Terms
Restricted Stock Units financial
derivative security financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UNITED THERAPEUTICS (UTHR) director Nilda Mesa report?
What type of derivative security was involved in the UTHR Form 4 for Nilda Mesa?
Do the restricted stock units in the UTHR filing have an expiration date?
AI-generated analysis. How Rhea-AI works. Not financial advice.